OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN:…
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates…
June 12, 2025 16:53 ET | Source: Fobi AI Inc. Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- FOBI AI…
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025…